Staphylococcus Aureus Surgical Site Infection Multinational Epidemiology in Europe
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
- Status
- COMPLETED
- Phase
- PHASE3
Sickle-cell Disease Registry of the GPOH
- Status
- RECRUITING
- Phase
- N/A
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2